I'm the Managing Director of Marketing, at RA Capital Management. I post about stuff we do - and do the other things. Opinions expressed here are my own.
Here's the link... to the article. The writing was the easy part. Huge thank you to everyone on our team who worked to get this put together. rapport.racap.com/all-storie…
Raj and I just dropped the 2026 Semper Maior report. 20 years of M&A lessons a massive deep dive into deal data since 2019. Lot's of hard-earned lessons in here.
Read it on your way to JPM before your strategic meetings. Good luck out there!
#JPM2026
💙 Tomorrow is #WorldMyositisDay.
50,000 Americans live with this autoimmune disease that weakens muscles and can make even breathing difficult.
#Biotech innovators are developing treatments. If you invest or pay insurance premiums, you may be helping them.
🎥 Learn how:
🩺 Today is #WorldLymphomaDay.
1 million Americans live with lymphoma today. Every year, 20,000 Americans die and 80,000 are newly diagnosed with this cancer of the immune system.
#Biomedical innovators are working on better treatments, and you may be helping.
🎥 Learn how:
We made this year's @FierceHealth 50 list!
What we're pushing for is not only possible, but crucial.
We don't have to settle for bad policies like MFN and the pill penalty. We CAN make meds more affordable AND protect innovation.
Learn about our work: fiercepharma.com/fierce-50/n…
The Fierce 50 of 2025 is here. This is our annual look at the people and organizations advancing what’s possible in healthcare and biopharma. fiercepharma.com/collection/…
Epileptic seizures can strike without warning, and 3 million Americans and 50 million people worldwide live with epilepsy.
Many small #Biotech companies are racing to develop cures, and you may be helping.
🎥 Learn how:
Today is #WorldHepatitisDay.
🧬 Millions live with liver disease. Thousands wait for a transplant they may never receive.
#Biotech teams are working urgently on new treatments. If you invest or pay insurance premiums, you may be helping.
At Trace, we think every person should have access to proper treatment for their disease, including those with #ALS. On #LouGehrigDay, we join @NPLB_org in their mission to make medicines affordable for every patient in America. @ercgrn joins fellow biotech leaders to share more.
Today is #NationalCancerSurvivorsDay. Behind every survivor is a story of patients and caregivers showing incredible strength, scientists chasing breakthroughs, startups pushing boundaries, and investors making bold bets.
📽️ nopatientleftbehind.org/our-…
Over 1.5M Americans live with blood cancer. Behind every patient is a team working for a cure—scientists, investors & advocates.
Price controls won’t get us there—smart insurance reform will.
🎥 Watch how you’re part of the progress:
👉 nopatientleftbehind.org/our-…#WorldBloodCancerDay#Biotech
We asked @t_lorriman about biotech startups.
"The entrepreneurial process for biotech is too institutionalized."
"Ideas (mostly) come out of academic and venture funds. Because biotech is so high-risk and capital intensive, there's more of an institutional process to start a company than in tech."
"China has a fundamentally different cost base and pace of iteration. There's a lot of work we need to consider for our biotech ecosystem to adapt."
We asked @t_lorriman about biotech startups.
"The entrepreneurial process for biotech is too institutionalized."
"Ideas (mostly) come out of academic and venture funds. Because biotech is so high-risk and capital intensive, there's more of an institutional process to start a company than in tech."
"China has a fundamentally different cost base and pace of iteration. There's a lot of work we need to consider for our biotech ecosystem to adapt."
3 million Americans are diagnosed with skin cancer each year.
Our new Community Quest video highlights biotech innovators working on new treatments.
Hear from them why we need to #FixInsurance so that patients can access their prescribed medicines at low out-of-pocket costs.
Nearly a million Americans are living with multiple sclerosis.
Meet some of the biotech innovators racing to develop breakthrough treatments for patients and their families still waiting for a cure.
Together, we can create a future without MS.
Massachusetts leads the world in biotech—yet its own leaders often criticize the industry that powers the state's economy and develops the new medicines we all depend on. Why?
Over 1,000 companies, 100,000 jobs, and a mission to save lives.
📺 Watch: The Massachusetts Paradox